Circulating Aryl Hydrocarbon Receptor Is Associated with Latent Tuberculosis Infection in Patients with Type 2 Diabetes.

Publication date: Jun 04, 2025

Latent tuberculosis infection (LTBI) is prevalent in patients with type 2 diabetes. We aimed to examine the relationship between serum levels of aryl hydrocarbon receptor (AhR) and LTBI in patients with type 2 diabetes. In this cross-sectional study, patients with type 2 diabetes were screened for LTBI using the QuantiFERON-TB (QFT) test. Of 543 patients screened for LTBI, 133 (24. 5%) were QFT-positive. The QFT-positive patients had higher AhR levels than the QFT-negative patients (44. 6 [interquartile range: 25. 4-58. 6] pg/mL vs. 37. 8 [interquartile range: 17. 4-55. 0] pg/mL; p = 0. 004). According to the receiver operating characteristic curve, the area under the curve was 0. 584 (95% confidence interval: 0. 528-0. 639; p = 0. 004) and the optimal cutoff value for serum AhR levels was of 37. 7 pg/mL for differentiating a QFT-positive result. By a multivariable logistic regression analysis, the patients with high AhR levels had a greater risk of being QFT positive than those with low AhR levels (odds ratio = 1. 902, 95% confidence interval: 1. 254-2. 886; p = 0. 003). In conclusion, in patients with type 2 diabetes, a high serum AhR level was associated with LTBI.

Open Access PDF

Concepts Keywords
Diabetes Adult
Hydrocarbon Aged
Serum AHR protein, human
Tb aryl hydrocarbon receptor
Biomarkers
Biomarkers
Cross-Sectional Studies
Diabetes Mellitus, Type 2
Female
Humans
Latent Tuberculosis
latent tuberculosis
Male
Middle Aged
Receptors, Aryl Hydrocarbon
Receptors, Aryl Hydrocarbon
ROC Curve
type 2 diabetes

Semantics

Type Source Name
disease MESH Latent Tuberculosis Infection
disease MESH Type 2 Diabetes
pathway REACTOME Metabolism
disease MESH Infectious Disease
pathway REACTOME Infectious disease
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH infection
disease MESH diabetes mellitus
drug DRUGBANK Gold
disease MESH inflammation
disease MESH oxidative stress
disease MESH overweight
disease MESH obesity
disease IDO blood
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Cholesterol
disease MESH hypertension
disease IDO history
drug DRUGBANK Rasagiline
drug DRUGBANK Metformin
disease IDO protein
drug DRUGBANK Saquinavir

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *